Indeed, the TNF-α cytokine, which is present at high levels in the AD brain, decreases both GFAP and S100B intracellular levels in astrocytes, while increasing their extracellular levels (Edwards and Robinson, 2006). Here, GFAP is linked to Alzheimer disease.